<?xml version="1.0" encoding="UTF-8"?>
<p>An interleukin (IL)-6 inhibitor has been tried in severe COVID-19 disease with raised IL-6 levels.[
 <xref rid="ref24" ref-type="bibr">24</xref>] A variety of other investigational molecules including ribavirin, immunoglobulins, washed microbiota transplant, combination of darunavir cobicistat, arbidol hydrochloride, sofosbuvir, favipiravir, and interferon are under the study for COVID-19.[
 <xref rid="ref25" ref-type="bibr">25</xref>
 <xref rid="ref26" ref-type="bibr">26</xref>]
</p>
